Abstract
Vincristine Sulfate Liposome Injection (VSLI) with Bendamustine and Rituximab As First-Line Therapy for Indolent B-Cell Lymphomas: A Phase 1 Study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have